Clinical Trial Update: A Case-control Study of the Efficacy of a New Serogroup A Meningococcal Conjugate Vaccine (MenAfriVac) in Mali and Niger

View source ↗

Summary

Status update indicating that the case-control trial evaluating the efficacy of MenAfriVac in Mali and Niger has been withdrawn. The study aimed to assess effic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenAfriVac (Meningococcal A conjugate vaccine)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Meningococcal Disease | Status: WITHDRAWN